Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity

Abstract

The inhibitor of DNA-binding/differentiation 3 (Id3) protein is a helix-loop-helix transcription factor and may have an important role in cell proliferation and differentiation. This study was to evaluate the effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity. Short interference RNA suppression of Id3 (miRId3) in A549 cells was used to investigate the functional role(s) of Id3. Next, we used in vitro wound-healing assay and trans-well assay to study the effects of overexpressed Id3 on migration and invasion of A549 cells. Furthermore, to explore the influence of overexpressed Id3 on in vivo tumorigenesis, adenoviruses containing Id3 gene (Ad-Id3) and empty vector (Ad-LacZ) were generated. Co-transfection of pcDNA/miRId3 and pEGFP/Id3 into A549 cells reversed the Id3-induced cell proliferation inhibition and apoptosis. Upon Id3 transfection, A549 cells displayed decreased migratory and invasive capabilities, however, co-transfection of miRId3 and Id3 into A549 cells reversed the Id3-induced inhibitions of migratory and invasive capabilities. Three groups of nude mice were inoculated with Ad-LacZ, Ad-Id3 transfectants and untransfected A549 cells, respectively. Twenty-eight days after inoculation, tumors induced by Ad-Id3 transfectants grew much more slowly compared with Ad-LacZ transfectants and control group. This study provides for the first time both in vitro and in vivo proofs that forced expression of Id3 in lung adenocarcinoma cells reduces tumor growth rate and may be a potential target for tumor suppression.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics. CA Cancer J Clin 2010; 60: 277–300.

    Article  Google Scholar 

  2. Tsuchiya T, Okaji Y, Tsuno NH, Sakurai D, Tsuchiya N, Kawai K et al. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 2005; 96: 784–790.

    Article  CAS  Google Scholar 

  3. Swarbrick A, Roy E, Allen T, Bishop JM . Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci USA 2008; 105: 5402–5407.

    Article  CAS  Google Scholar 

  4. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC . Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 2003; 22: 4498–4508.

    Article  CAS  Google Scholar 

  5. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 2007; 104: 19506–19511.

    Article  CAS  Google Scholar 

  6. Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C et al. Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008; 14: 2318–2325.

    Article  CAS  Google Scholar 

  7. Kebebew E, Peng M, Treseler PA, Clark OH, Duh QY, Ginzinger D et al. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells. J Clin Endocrinol Metab 2004; 89: 6105–6111.

    Article  CAS  Google Scholar 

  8. Maw MK, Fujimoto J, Tamaya T . Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009; 9: 430.

    Article  Google Scholar 

  9. Okaji Y, Tsuno NH, Kitayama J, Sakurai D, Tsuchiya N, Saito S et al. Effects of down-regulating the Id genes in human colorectal cancer cells on early steps of haematogenous metastasis. Eur J Cancer 2006; 42: 668–673.

    Article  CAS  Google Scholar 

  10. Manthey C, Mern DS, Gutmann A, Zielinski AJ, Herz C, Lassmann S et al. Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells. BMC Cell Biol 2010; 11: 2.

    Article  Google Scholar 

  11. Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D . An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc Natl Acad Sci USA 1991; 88: 1815–1819.

    Article  CAS  Google Scholar 

  12. Lim RW, Wu JM . Molecular mechanisms regulating expression and function of transcription regulator inhibitor of differentiation 3. Acta Pharmacol Sin 2005; 26: 1409–1420.

    Article  CAS  Google Scholar 

  13. Kee BL, Rivera RR, Murre C . Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol 2001; 2: 242–247.

    Article  CAS  Google Scholar 

  14. Thal MA, Carvalho TL, He T, Kim HG, Gao H, Hagman J et al. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci USA 2009; 106: 552–557.

    Article  CAS  Google Scholar 

  15. Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, Pandolfi PP et al. Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol 2010; 184: 1268–1279.

    Article  CAS  Google Scholar 

  16. Maruyama T, Li J, Vaque JP, Konkel JE, Wang W, Zhang B et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol 2011; 12: 86–95.

    Article  CAS  Google Scholar 

  17. Felty Q, Porther N . Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells. Atherosclerosis 2008; 198: 12–21.

    Article  CAS  Google Scholar 

  18. Wassmann K, Mueller CF, Becher UM, Werner C, Jung A, Zimmer S et al. Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Kruppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells. Mol Cell Biochem 2010; 333: 33–39.

    Article  CAS  Google Scholar 

  19. Zhao Q, Beck AJ, Vitale JM, Schneider JS, Gao S, Chang C et al. Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes. Dev Biol 2011; 349: 53–64.

    Article  CAS  Google Scholar 

  20. Shuno Y, Tsuno NH, Okaji Y, Tsuchiya T, Sakurai D, Nishikawa T et al. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer. J Surg Res 2010; 161: 76–82.

    Article  CAS  Google Scholar 

  21. Kamalian L, Gosney JR, Forootan SS et al. Increased expression of ID family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008; 14: 2318–2325.

    Article  CAS  Google Scholar 

  22. Fong S, Debs RJ, Desprez PY . Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004; 10: 387–392.

    Article  CAS  Google Scholar 

  23. Arnold JM, Mok SC, Purdie D, Chenevix-Trench G . Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br J Cancer 2001; 84: 352–359.

    Article  CAS  Google Scholar 

  24. Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T et al. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 2005; 26: 319–327.

    CAS  PubMed  Google Scholar 

  25. Li XJ, Jia L, Chen FF, Zhong AF, Yu W, Wang K et al. Soluble expression of human Id(3) in Escherichia coli and generation and application of its polyclonal antibodies. Biotechnol Appl Biochem 2011; 58: 91–96.

    Article  CAS  Google Scholar 

  26. Li XJ, Zhu CD, Yu W, Wang P, Chen FF, Xia XY et al. Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells. Cell Prolif 2012; 45: 1–8.

    Article  CAS  Google Scholar 

  27. Lee SH, Hao E, Kiselyuk A, Shapiro J, Shields DJ, Lowy A et al. The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma. Mol Cancer Res 2011; 9: 782–790.

    Article  CAS  Google Scholar 

  28. Kamalian L, Forootan SS, Bao ZZ, Zhang Y, Gosney JR, Foster CS et al. Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression. Int J Oncol 2010; 37: 595–603.

    CAS  PubMed  Google Scholar 

  29. Mern DS, Hoppe-Seyler K, Hoppe-Seyler F, Hasskarl J, Burwinkel B . Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 2010; 124: 623–633.

    Article  CAS  Google Scholar 

  30. Hata K, Yoshimoto T, Mizuguchi J . CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J Immunol 2004; 173: 2453–2461.

    Article  CAS  Google Scholar 

  31. Li XJ, Hata K, Mizuguchi J . Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells. Acta Pharmacol Sin 2005; 26: 486–491.

    Article  CAS  Google Scholar 

  32. Simbulan-Rosenthal CM, Daher A, Trabosh V, Chen WC, Gerstel D, Soeda E et al. Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6/7 immortalized human keratinocytes. Oncogene 2006; 25: 3649–3660.

    Article  CAS  Google Scholar 

  33. Trabosh VA, Daher A, Divito KA, Amin K, Simbulan-Rosenthal CM, Rosenthal DS . UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3. Exp Dermatol 2009; 18: 387–395.

    Article  CAS  Google Scholar 

  34. Lee YS, Mollah ML, Sohn KC, Shi G, Kim DH, Kim KH et al. ID3 mediates X-ray-induced apoptosis of keratinocytes through the regulation of beta-catenin. J Dermatol Sci 2010; 60: 138–142.

    Article  CAS  Google Scholar 

  35. Langenfeld E, Deen M, Zachariah E, Langenfeld J . Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer 2013; 12: 129.

    Article  Google Scholar 

  36. Chen D, Forootan SS, Gosney JR, Forootan FS, Ke Y . Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer. Genes Cancer 2014; 5: 212–225.

    PubMed  PubMed Central  Google Scholar 

  37. Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM . Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med 2013; 11: 13.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the grant from National Natural Science Foundation of China (NSFC 81171652). We thank International Science Editing for language editing of the manuscript.

Author contributions

FFC and YL participated in the design of the study and performed the statistical analysis; FFC, YL, X-JP, C-DZ and X-JL performed research; FFC, YL, MX, FW, WY and X-JL have been involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X-J Li.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, FF., Liu, Y., Wang, F. et al. Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity. Cancer Gene Ther 22, 431–437 (2015). https://doi.org/10.1038/cgt.2015.38

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2015.38

This article is cited by

Search

Quick links